Kidney cancer
 | Votrient is targeted therapy for metastatic renal-cell carcinoma
- Votrient is used to treat kidney cancer. It may also be used to treat certain other types of cancer (soft tissue sarcoma). Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors. » By Robina Anderson, created on Sep. 15 2014 In Press Releases and Company Profiles |
| | Votrient works by blocking signals within the cancer cells-cheapharmacy
- Votrient (pazopanib) is a cancer medication that interferes with the growth of cancer cells and slows their spread in the body. Votrient is used to treat advanced renal cell carcinoma (kidney cancer). » By Harry Roberts, created on June 17 2014 In Press Releases and Company Profiles |
| | Drug approved by FDA treating Chronic Fatigue Syndrome - Zeepharmacy.co - A professional team of medical experts in USFDA (United States Food & Drug Association) have authorized the utilization of a novel medicinal product which has been found to be essential for the treatment of chronic fatigue syndrome. » By Camili Smith, created on Sep. 26 2013 In Press Releases and Company Profiles |
| | Nexavar or Sorafenib stops the growth of metastatic thyroid cancer by nearly 5 months - Jellypharmacy.com - If the FDA (Food and Drug Administration) approves liver and kidney cancer drug Nexavar it would be the first effective agent for the use in radioactive iodine-refractory differentiated thyroid cancer. » By Wilson Martin, created on Jul. 20 2013 In Press Releases and Company Profiles |
